Zhang B, Lang Z, Zhu K, Luo W, Zhao Z, Zhang Z
BMC Gastroenterol. 2025; 25(1):161.
PMID: 40069629
PMC: 11900024.
DOI: 10.1186/s12876-025-03761-x.
Ho I, Chiang N, Lai J, Chang P, Chen S, Hung Y
Oncologist. 2025; 30(3).
PMID: 40063612
PMC: 11892555.
DOI: 10.1093/oncolo/oyae372.
Ma J, Tang Y, He W, Shi J
Gynecol Oncol Rep. 2025; 58:101692.
PMID: 40034377
PMC: 11872545.
DOI: 10.1016/j.gore.2025.101692.
Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T
J Clin Invest. 2025; 135(5).
PMID: 40026252
PMC: 11870734.
DOI: 10.1172/JCI186702.
Ranallo N, Roncadori A, Gentili N, Balzi W, Altini M, Ghini V
Biomedicines. 2025; 13(2).
PMID: 40002928
PMC: 11852996.
DOI: 10.3390/biomedicines13020515.
Radiological Variability in Pancreatic Neuroendocrine Neoplasms: A 10-Year Single-Center Study on Atypical Presentations and Diagnostic Challenges.
Danek E, Kavnoudias H, McLean C, Gerstenmaier J, Di Muzio B
Biomedicines. 2025; 13(2).
PMID: 40002909
PMC: 11853254.
DOI: 10.3390/biomedicines13020496.
Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows.
Medici B, Caffari E, Maculan Y, Benatti S, Piacentini F, Dominici M
Biomedicines. 2025; 13(2).
PMID: 40002868
PMC: 11853220.
DOI: 10.3390/biomedicines13020455.
"Cold" Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy.
Massironi S, Albertelli M, Hasballa I, Paravani P, Ferone D, Faggiano A
Cells. 2025; 14(4).
PMID: 39996718
PMC: 11854070.
DOI: 10.3390/cells14040245.
Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center.
Melhorn P, Spitzer J, Adel T, Wolff L, Mazal P, Raderer M
J Cancer Res Clin Oncol. 2025; 151(2):86.
PMID: 39971811
PMC: 11839849.
DOI: 10.1007/s00432-025-06126-9.
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study.
Massironi S, Gallo C, Coltro L, DellAnna G, Preatoni P, Danese S
J Endocrinol Invest. 2025; .
PMID: 39969798
DOI: 10.1007/s40618-025-02552-1.
Machine learning based predictive model and genetic mutation landscape for high-grade colorectal neuroendocrine carcinoma: a SEER database analysis with external validation.
Wu R, Chen S, He Y, Li Y, Mu S, Jin A
Front Oncol. 2025; 15:1509170.
PMID: 39944824
PMC: 11813786.
DOI: 10.3389/fonc.2025.1509170.
Pancreatic Neuroendocrine Tumors-Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report.
Popa S, Golli A, Matei C, Sonei A, Vere C, Cimpeanu R
Diagnostics (Basel). 2025; 15(3).
PMID: 39941267
PMC: 11816404.
DOI: 10.3390/diagnostics15030337.
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges.
de Ponthaud C, Gelu-Simeon M, Zabulon A, Dubreuil O, de Mestier A, de Mestier L
Hepatobiliary Surg Nutr. 2025; 14(1):143-146.
PMID: 39925915
PMC: 11806153.
DOI: 10.21037/hbsn-2024-643.
Structured reporting of neuroendocrine tumors in PET/CT using [F]SiTATE - impact on interdisciplinary communication.
Hinterberger A, Trupka L, Kortbein S, Ebner R, Fink N, Froelich M
Sci Rep. 2025; 15(1):4793.
PMID: 39922882
PMC: 11807131.
DOI: 10.1038/s41598-025-88999-x.
Low-activity [F]-somatostatin receptor (SSTR) imaging using [F]SiTATE on a long axial field-of-view PET/CT scanner.
Trautwein N, Calderon E, Linder P, Reischl G, Driessen P, Lan W
EJNMMI Phys. 2025; 12(1):13.
PMID: 39907960
PMC: 11799470.
DOI: 10.1186/s40658-025-00720-z.
A rare case of a rectal neuroendocrine neoplasm growing within a lipoma with ulcerative lesions.
Zhang X, Duan H, Yue S, Gong L, Liao F
Wien Klin Wochenschr. 2025; .
PMID: 39900808
DOI: 10.1007/s00508-024-02498-z.
Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumors.
Gao Y, Zheng H, Ye M, Zhou G, Chen J, Qiang X
J Cancer. 2025; 16(4):1040-1050.
PMID: 39895797
PMC: 11786048.
DOI: 10.7150/jca.103297.
Rare epithelial gastric cancers: a review of the current treatment knowledge.
Petrillo A, Ottaviano M, Pompella L, Giunta E, Pisapia P, Marte G
Ther Adv Med Oncol. 2025; 17:17588359241255628.
PMID: 39867743
PMC: 11760139.
DOI: 10.1177/17588359241255628.
Predictive and prognostic nomogram models for liver metastasis in colorectal neuroendocrine neoplasms: a large population study.
Lei X, Su Y, Lei R, Zhang D, Liu Z, Li X
Front Endocrinol (Lausanne). 2025; 15():1488733.
PMID: 39839478
PMC: 11746099.
DOI: 10.3389/fendo.2024.1488733.
Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask.
Ruz-Caracuel I, Pedraza-Arevalo S, Alonso-Gordoa T, Molina-Cerrillo J, Earl J, Sainz Jr B
Endocr Oncol. 2025; 4(1):e240006.
PMID: 39822777
PMC: 11737516.
DOI: 10.1530/EO-24-0006.
